Roche Holding traded at 323.15 this Wednesday July 6th, increasing 4.15 or 1.30 percent since the previous trading session. Looking back, over the last four weeks, Roche Holding gained 1.49 percent. Over the last 12 months, its price fell by 9.21 percent. Looking ahead, we forecast Roche Holding to be priced at 312.13 by the end of this quarter and at 288.59 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
323.15
Daily Change
1.30%
Yearly
-9.21%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.93 0.13 0.08% 33.01%
Alcon AG 68.38 0.54 0.80% 3.51%
Almirall SA 10.72 -0.15 -1.38% -28.82%
Amgen 246.73 1.18 0.48% 1.26%
Artemis Alpha 305.00 7.00 2.35% -31.15%
AstraZeneca 10,943.24 143.24 1.33% 26.39%
Bayer 56.47 0.95 1.71% 10.79%
Biogen 212.58 1.95 0.93% -38.36%
Bristol-Myers Squibb 75.96 -0.88 -1.15% 13.97%
Fresenius Medical Care 47.88 0.62 1.31% -30.41%
Fresenius 29.05 0.52 1.82% -34.27%
Genmab 2,404.00 -3.00 -0.12% -10.23%
Gilead Sciences 62.34 -0.02 -0.03% -8.87%
Galapagos 55.40 0.50 0.91% -2.31%
GRIFOLS 16.96 -0.61 -3.45% -23.63%
GlaxoSmithKline 1,794.20 7.60 0.43% 24.86%
Hikma Pharmaceutical 1,656.00 18.00 1.10% -35.76%
Eli Lilly 327.18 2.47 0.76% 38.98%
Lonza Group 539.00 9.40 1.77% -20.64%
Merck 168.65 0.80 0.48% -0.18%
Merck & Co 92.64 0.22 0.24% 18.60%
Novartis 81.27 0.36 0.44% -4.35%
Orion 43.23 -0.49 -1.12% 16.49%
Pfizer 51.64 -0.67 -1.28% 31.43%
Philips 20.59 0.53 2.62% -48.82%
Recordati 42.37 -0.54 -1.26% -18.11%
Regeneron Pharmaceuticals 596.56 1.16 0.19% 2.46%
Roche Holding 323.15 4.15 1.30% -9.21%
Sanofi 97.75 0.63 0.65% 12.62%
UCB 84.06 1.46 1.77% -5.55%

Indexes Price Day Year
CH20 10820 117.62 1.10% -10.47%

Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.